Kirkland & Ellis LLP advised GTCR Golder Rauner LLC and its portfolio company Devicor Medical Products, Inc., on the financing for and acquisition of the Breast Care Business of Ethicon-Endo Surgery, a Johnson & Johnson company. The EES Breast Care product portfolio is sold in 50 countries around the world. The acquisition closed in the United States on July 12, 2010, and will be completed in other countries later this year.
The global Kirkland team includes Chicago partners Sanford Perl (Corporate) and Michael Weed (Corporate), with associate Erik Knudsen (Corporate), and Munich partners Sacha Lürken (Restructuring/Finance) and Dr. Christian Zuleger (Corporate), with associates Dominik Stühler (Corporate), Katrin Schreiber (Finance) and Dr. Kai Terstiege (Corporate).
About Devicor Medical Products
Devicor Medical Products, Inc. (www.devicormedical.com) is a newly formed company focusing on minimally invasive medical procedures, with an initial focus on the vacuum assisted breast biopsy market. The company is dedicated to building a global business through the investment in, and development of, tools and technologies that facilitate minimally invasive procedures.
About GTCR Golder Rauner
Founded in 1980, GTCR Golder Rauner, LLC (www.gtcr.com) is a leading private equity firm focused on investing in growth companies in the financial services and technology, healthcare and information services and technology industries. The Chicago-based firm pioneered the "Leaders Strategy" – finding and partnering with world-class leaders as the critical first step in identifying, acquiring and building market-leading companies through acquisitions and organic growth. Since its inception, GTCR has invested more than $8.0 billion in over 200 companies.
About Kirkland & Ellis
Kirkland & Ellis is a 1,500-attorney law firm representing global clients in complex private equity, corporate, restructuring, tax, intellectual property, litigation and dispute resolution/arbitration matters. The Firm has offices in Chicago, Hong Kong, London, Los Angeles, Munich, New York, Palo Alto, San Francisco, Shanghai, and Washington, D.C. The Munich office consists of 25 attorneys who focus primarily on private equity, mergers & acquisitions, restructuring/insolvency, acquisition financing and tax.